What it is
FOXO4-DRI is a synthetic peptide designed to target and clear senescent cells, which accumulate with age. It is researched for its potential role in supporting cellular longevity and healthy aging processes.
Supplement · Peptide
FOXO4-DRI
5 mg · vegan · gluten-free · 30 caps
premature-agingfatiguecellular-stress mitochondriacell
Affiliate link · we earn from qualifying purchases. No paid placements.
How it works
This peptide functions by inducing apoptosis in senescent cells, thereby reducing their pro-inflammatory and tissue-damaging effects. Its action is primarily intracellular, influencing cellular repair and rejuvenation pathways.
Who should take it
Adults looking to address premature ageing, low energy, cellular stress. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
Avoid / careful
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
When to take it
Morning
Noon
Evening
Night
How to take it
With food
Empty stomach
Before food
FAQs
Frequently asked
What are senescent cells?
Senescent cells are aged cells that stop dividing but remain metabolically active, releasing inflammatory signals that can damage surrounding tissues and contribute to aging.
How long does it take to see effects?
Effects on longevity markers are typically measurable within 8-12 weeks of consistent daily use.
Can FOXO4-DRI be combined with other supplements?
Yes, it can be layered into a broader protocol. Consult with a healthcare professional for personalized recommendations.
Research
6 studies · 2010–2024
Evidence grade
ABCD
C · C · emerging-to-moderate human evidence for healthy ageing and cellular longevity
From the blog
Editorial notes
SacredBod's longer take on FOXO4-DRI — context the structured blocks above don't capture.
About FOXO4-DRI
FOXO4-DRI is a peptide supplement used to support healthy ageing and cellular longevity. Senolytic peptide researched for clearing senescent cells. It is available in capsule form and dosed for adults in India and internationally. As a peptide-tradition entry in the SacredBod catalog, it is positioned as a single-ingredient option that can be used on its own or layered into a broader protocol. FOXO4-DRI works through the mechanisms characteristic of its class — see the mechanism and research sections for detail. It primarily acts on the mitochondria, cells, telomeres, and effects are dose-dependent, typically becoming measurable within 8-12 weeks for longevity markers. Consistency matters more than dose size for this category.
Evidence
FOXO4-DRI carries an evidence grade of C in the SacredBod catalog, reflecting emerging human evidence for healthy ageing and cellular longevity. Senolytic peptide researched for clearing senescent cells. Benefits are cumulative rather than immediate, typically becoming noticeable within 8-12 weeks for longevity markers, and individual response varies.
Dosing
A typical dose is 5 mg, taken with food, usually in the morning. Start at the lower end, assess tolerance, and stay consistent; more is not automatically better.
Cautions
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
Who it’s for
Adults looking to address premature ageing, low energy, cellular stress. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
As part of the Peptide category, FOXO4-DRI can be used on its own or layered into a broader protocol — see the Goes with panel for evidence-aligned pairings.
Added to your stack.